Biotechnology Assets S.A. Free Cash Flow Generation Index

Latest as of June 2025: 1.00x

Biotechnology Assets S.A. free cash flow generation index. Biotechnology Assets S.A. (BST) has a Free Cash Flow Generation Index of 1.00x as of June 2025. Free cash flow of €656.15K represents 1% of operating cash flow (€658.13K).

FCF Generation Index

1.00x
Free Cash Flow / Operating CF

Free Cash Flow

€656.15K
EUR

Operating Cash Flow

€658.13K
EUR

Capital Expenditures

€1.99K
EUR

Free Cash Flow Generation Index of Biotechnology Assets S.A. (2015–2023)

Free cash flow generation index of Biotechnology Assets S.A. from 2015 to 2023. Historical FCF Generation Index trend for Biotechnology Assets S.A. across 5 annual periods. See financial flexibility index of Biotechnology Assets S.A. to measure the company's free cash flow as a share of total liabilities.

Biotechnology Assets S.A. Free Cash Flow Generation Index by Year (2015–2023)

Biotechnology Assets S.A. free cash flow generation index by year from 2015 to 2023. Year-by-year Free Cash Flow Generation Index for Biotechnology Assets S.A.. For the full cash flow conversion analysis, see cash flow conversion of Biotechnology Assets S.A..

Year FCG Index Free Cash Flow (EUR) Operating CF Capital Expenditures YoY Change
2023 -5.83x €-278.23K €47.74K €325.97K ▼ -710.0%
2020 0.96x €8.40 Million €8.79 Million €391.53K ▲ +115.1%
2017 -6.33x €-1.35 Million €213.49K €1.56 Million ▼ -2994.9%
2016 -0.20x €-555.22K €2.71 Million €3.27 Million ▲ +96.4%
2015 -5.75x €-910.02K €158.16K €1.07 Million —
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).